Baxter Healthcare Corporation, in conjunction with U.S. Food and Drug Administration, has initiated temporary importation of Dianeal PD4 Glucose Solutions for Peritoneal Dialysis into the U.S. market to address a shortage, the FDA announced. Baxter will import PD solutions manufactured at the company's Castlebar, Ireland facility. The FDA said it estimates the additional solution will be available beginning in November. 

Please see the healthcare professional and consumer letters for additional product and supply information, including a comparison guide. Once the product is available in the United States clinicians will be able to contact their Baxter Clinical Educator for further information and it will be available for order through Baxter’s Home Care Services at 800.284.4060.